Primer:
1608 | H2A.V_FWD | TGCTTTCTGTGTGCCCTTCT | JH | 5/21/2015 | 20 | 55 | O.lurida | Histone H2A.V (H2A.F/Z) (Fragment) | P08991 | |
1607 | H2A.V_REV | TATCACACCCCGTCACTTGC | JH | 5/21/2015 | 20 | 55 | O.lurida | Histone H2A.V (H2A.F/Z) (Fragment) | P08991 |
Reagent Table:
Volume | Reactions X116 | |
Ssofast Evagreen MM | 10 | 1160 |
FWD Primer | 0.5 | 58 |
REV Primer | 0.5 | 58 |
1:9 cDNA | 9 |
- Added reagents from greatest to least volume
- Vortexed
- Centrifuged briefly
- Pipetted 11 ul Master Mix to each tube
- Pipetted 9 ul of 1:9 cDNA each column using a channel pipetter
- Centrifuged plate at 2000 rpm for 1 minute
- Ran Program Below
Program:
Step | Temperature | Time |
Initiation | 95 C | 10 min |
Elongation | 95 C | 30 sec |
60 C | 1 min | |
Read | ||
72 C | 30 sec | |
Read | ||
Repeat Elongation 39 times | ||
Termination | 95 C | 1 min |
55 C | 1 sec | |
Melt Curve Manual ramp 0.2C per sec Read 0.5 C | 55 - 95 C | 30 sec |
21 C | 10 min | |
End |
Plate Layout:
1 | 2 | 3 | 4 | 5 | 6 | 7 |
DNased 42215 HC1 | DNased 42215 NC1 | DNased 42215 SC1 | DNased 42215 HT1 1 | DNased 42215 NT1 1 | DNased 42215 ST1 1 | NTC |
DNased 42215 HC2 | DNased 42215 NC2 | DNased 42215 SC2 | DNased 42215 HT1 2 | DNased 42215 NT1 2 | DNased 42215 ST1 2 | NTC |
DNased 42215 HC3 | DNased 42215 NC3 | DNased 42215 SC3 | DNased 42215 HT1 3 | DNased 42215 NT1 3 | DNased 42215 ST1 3 | NTC |
DNased 42215 HC4 | DNased 42215 NC4 | DNased 42215 SC4 | DNased 42215 HT1 4 | DNased 42215 NT1 4 | DNased 42215 ST1 4 | NTC |
DNased 42215 HC5 | DNased 42215 NC5 | DNased 42215 SC5 | DNased 42215 HT1 5 | DNased 42215 NT1 5 | DNased 42215 ST1 5 | |
DNased 42215 HC6 | DNased 42215 NC6 | DNased 42215 SC6 | DNased 42215 HT1 6 | DNased 42215 NT1 6 | DNased 42215 ST1 6 | |
DNased 42215 HC7 | DNased 42215 NC7 | DNased 42215 SC7 | DNased 42215 HT1 7 | DNased 42215 NT1 7 | DNased 42215 ST1 7 | |
DNased 42215 HC8 | DNased 42215 NC8 | DNased 42215 SC8 | DNased 42215 HT1 8 | DNased 42215 NT1 8 | DNased 42215 ST1 8 |
Results:
All samples
NTCs
The run looks great with no amplification in the NTCs besides some very minor primer amp near the end. To see if this is a useful target for normalization. I need to run an ANOVA and Tukey's HSD to see if there are any significant differences between treatment and control.
Call:
aov(formula = expression ~ Pop + Treat + Pop:Treat, data = rep2res2)
Terms:
Pop Treat Pop:Treat Residuals
Sum of Squares 7.838900e-21 6.598200e-21 7.200100e-20 5.079214e-19
Deg. of Freedom 2 1 2 42
Residual standard error: 1.099698e-10
Estimated effects may be unbalanced
> TukeyHSD(fit)
Tukey multiple comparisons of means
95% family-wise confidence level
Fit: aov(formula = expression ~ Pop + Treat + Pop:Treat, data = rep2res2)
$Pop
p adj
N-H 0.8595743
S-H 0.7104965
S-N 0.9617483
$Treat
p adj
T-C 0.4642267
$`Pop:Treat`
p adj
N:C-H:C 0.5748629
S:C-H:C 0.9999654
H:T-H:C 0.9999759
N:T-H:C 0.9773963
S:T-H:C 0.8762900
S:C-N:C 0.6926732
H:T-N:C 0.6846405
N:T-N:C 0.1895419
S:T-N:C 0.9942013
H:T-S:C 1.0000000
N:T-S:C 0.9404714
S:T-S:C 0.9396392
N:T-H:T 0.9438669
S:T-H:T 0.9360823
S:T-N:T 0.4563546
Interestingly there are no significant differences between any of the treatments, controls, or populations. It does appear that it is close for the Fidalgo Treatment and Control (NT:NC) but still not significant. This may be a good gene for normalization purposes.
You can see the raw data here.
No comments:
Post a Comment